RBI imposes Rs 30 million penalty on Lakshmi Vilas Bank

The action is based on deficiencies in regulatory compliance

GN Bureau | January 7, 2017


#Reserve Bank of India   #Banking  

The Reserve Bank of India has imposed a monetary penalty of Rs 30 million on Lakshmi Vilas Bank Ltd. (LVB) for contravention of instructions relating to opening and operation of current accounts, extending bill discounting facilities to non-constituents and walk-in customers and non-adherence to KYC norms.

“This action is based on deficiencies in regulatory compliance and is not intended to pronounce upon the validity of any transaction or agreement entered into by the bank and its customers,” said a press release.

RBI had received a complaint regarding irregularities in bill discounting/purchasing at one of the bank’s branches. RBI carried out an examination of the irregularities. Explanation from the bank was also obtained by RBI. On the basis of the examination of RBI and explanation furnished by the bank, a show cause notice was issued to the bank for violation of certain regulations and instructions issued by RBI.

After considering the bank’s reply, as also, personal submissions, information submitted and documents furnished, the RBI came to the conclusion that these violations were substantiated and warranted imposition of monetary penalty.

Comments

 

Other News

BFSI Needs Military-grade Cybersecurity Solutions to Detect the Most Advanced Attacks: Deloitte

In such unprecedented times, businesses are facing different kinds of risk, which has

“New guidelines suppress digital, social media, and OTT platforms”

The government’s recent notification to regulate digital media is an attempt to suppress all social media platforms including digital news platforms, Dr. Shama Mohamed, Congress Spokesperson, has said. Only digital news platforms are able to say what they want to say, so the government

Covaxin Phase 3 clinical trial shows 81% efficacy

India’s first indigenously produced Covid-19 vaccine, Covaxin, has shown an interim efficacy of 81% in Phase III trials for preventing the virus. Covaxin has been developed in India jointly by the Indian Council of Medical Research (ICMR) along with Bharat Biotech International Limited (BBIL). &

In Mumbai, 29 private hospitals join vaccination drive

In order to expand the vaccination drive, the centre has allowed 29 private hospitals in Mumbai not empanelled in central and state health schemes to be designated as Covid Vaccination Centres (CVC). After a virtual meeting with the chief minister and the BMC commissioner Tuesday evening, th

Spectrum auction concludes; response better than expected

India on Tuesday concluded the spectrum auction after a total of six rounds of bidding. The authorities described the response as better than expected, with total bids valued at Rs 77,814.80 crore. The quality of service and customer experience is expected to improve with deployment of additional spectrum

Covid-19 has increased nutrition gap. Public feeding programmes need to be enhanced

One of the most significant setbacks from the massive upheaval caused by the Covid-19 pandemic is its effect on food and nutrition security. The pandemic has compounded the already rampant social inequity by adversely affecting the socio-economic status of millions of families across the nation. In the giv

Visionary Talk Series with Dr. Shama Mohamed On the present state of Governance



Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter